Susan M. Molineaux

About

Susan M. Molineaux, Ph.D. is a biotechnology executive and scientist who co-founded Calithera Biosciences and previously co-founded Proteolix, which was acquired by Onyx Pharmaceuticals in 2009. She has held senior operating roles across oncology and drug development, including CEO roles at Calithera and Para Therapeutics. She currently serves as Executive Chair of Seranova Bio and has held public-company board and advisory roles including Geron, Repare Therapeutics, and Lightstone Ventures.

Areas of interest